Carin A. Uyl‐de Groot
- Oncology top 2%
- Pulmonary and Respiratory Medicine top 2%
- Economics and Econometrics top 1%
- Hematology top 2%
- Molecular Biology
- Co-authors
- Ken RedekopPieter SonneveldM FrankenHedwig M. BlommesteinMartijn GrootMichel van AgthovenPeter C. HuijgensBob Löwenberg
- Topics
- Health Systems, Economic Evaluations, Quality of Life (63 papers)Economic and Financial Impacts of Cancer (35 papers)Multiple Myeloma Research and Treatments (22 papers)
- Journals
- JAMAJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- NetherlandsUnited KingdomUnited States
In The Last Decade
Carin A. Uyl‐de Groot
202 papers receiving 3.6k citations
Peers
Comparison fields: 5 of 147
- Oncology 1.5k
- Pulmonary and Respiratory Medicine 905
- Economics and Econometrics 889
- Hematology 512
- Molecular Biology 436
Countries citing papers authored by Carin A. Uyl‐de Groot
This map shows the geographic impact of Carin A. Uyl‐de Groot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carin A. Uyl‐de Groot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carin A. Uyl‐de Groot more than expected).
Fields of papers citing papers by Carin A. Uyl‐de Groot
This network shows the impact of papers produced by Carin A. Uyl‐de Groot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carin A. Uyl‐de Groot. The network helps show where Carin A. Uyl‐de Groot may publish in the future.
Co-authorship network of co-authors of Carin A. Uyl‐de Groot
This figure shows the co-authorship network connecting the top 25 collaborators of Carin A. Uyl‐de Groot. A scholar is included among the top collaborators of Carin A. Uyl‐de Groot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carin A. Uyl‐de Groot. Carin A. Uyl‐de Groot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 18 | |
| 5 | 17 | |
| 6 | 10 | |
| 7 | 3 | |
| 8 | 43 | |
| 9 | 6 | |
| 10 | 5 | |
| 11 | 7 | |
| 12 | 27 | |
| 13 | 20 | |
| 14 | 26 | |
| 15 | 26 | |
| 16 | 25 | |
| 17 | 12 | |
| 18 | 108 | |
| 19 | Economic evaluation of prophylactic granulocyte colony stimulating factor during chemotherapy in elderly patients with aggressive non-Hodgkin's lymphoma. | 23 |
| 20 | 22 |
About Carin A. Uyl‐de Groot
Carin A. Uyl‐de Groot is a scholar working on Otorhinolaryngology, Hematology and Oncology, having authored 217 papers that have together received 3.7k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (63 papers), Economic and Financial Impacts of Cancer (35 papers) and Multiple Myeloma Research and Treatments (22 papers). The work is most often cited by research in Otorhinolaryngology (237 citations), Oncology (1.5k citations) and Hematology (512 citations). Carin A. Uyl‐de Groot has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Ken Redekop, Pieter Sonneveld, M Franken, Hedwig M. Blommestein, Martijn Groot, Michel van Agthoven, Peter C. Huijgens, Bob Löwenberg, Matthijs Versteegh and Elly Stolk. Their work appears in journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.